Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesPrognosis of refractory neurosarcoidosis altered by thalidomide: a case report
BMC Dermatology, 02/13/08
Hoyle JC et al. - halidomide has been shown to have activity specific to the inflammatory mediators of sarcoidosis, has been shown to be beneficial in cutaneous sarcoidosis, and provides an interesting observation in our patient with refractory neurosarcoidosis. Our case report presents a difficult, refractory case of neurosarcoidosis that demonstrates an altered prognosis based on the addition of thalidomide.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma
Journal of Allergy and Clinical Immunology, 12/08/09
Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/08/09
Today in Sarcoidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Sarcoidosis Presenting as an Epididymal Mass
Journal of the American Osteopathic Association, 12/08/09
Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
European Respiratory Review, 12/07/09
Functional analysis of dendritic cell–T cell interaction in sarcoidosis
Clinical and Experimental Immunology, 12/03/09
Sponsor
Article Search
Sponsor